Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

VGHCX vs. IDNA: which is better?

Bottom line

VGHCX vs IDNA: the short answer

VGHCX (Vanguard Health Care Fund) and IDNA (iShares Genomics Immunology and Healthcare ETF) are quite different portfolios: only about 17% of their top holdings (by weight) are shared.

VGHCX is cheaper at 0.33% vs 0.47% — a difference of $14 a year per $10,000 invested.

Over five years, VGHCX returned +6.6% a year vs −4.8% for IDNA (reporting dates differ).

Updated Nov 19, 2026

VGHCX vs IDNA side by side

VGHCXIDNA
TypeMutual fundETF
Fund familyVanguardiShares
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.33%0.47%
Annual cost per $10k$33$47
10-yr cost on $10k (prospectus)$418$591
Max front load0%None
12b-1 fee0%0%
1-yr return+17.3%−1.0%
5-yr return (annualized)+6.6%−4.8%
10-yr return (annualized)+7.7%—
Best quarter+16.8%+41.9%
Worst quarter−12.3%−21.5%
Net assets (fund)$38.2B$190.9M
Number of holdings9761
Portfolio turnover47%49%
Returns as ofDec 31, 2025Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearVGHCXIDNADifference
2024−1.6%−1.0%−0.6%
2023+5.4%−7.8%+13.2%
2022−1.1%−42.1%+41.1%
2021+14.3%−4.0%+18.3%
2020+12.6%+54.5%−41.9%

Source: Fund prospectus bar charts

Holdings overlap

5 of VGHCX's top 25 holdings also appear in IDNA's top 25.

Shared top holdings
HoldingVGHCXIDNA
Merck & Co Inc5.44%3.91%
Gsk Plc3.00%3.63%
Vertex Pharmaceuticals Inc2.36%3.87%
Regeneron Pharmaceuticals Inc2.14%4.35%
Roche Holding AG1.18%3.85%

Source: SEC Form N-PORT

VGHCX top 10

  1. Eli Lilly & Co — 8.61%
  2. Merck & Co Inc — 5.44%
  3. Johnson & Johnson — 4.83%
  4. AstraZeneca PLC — 4.59%
  5. UnitedHealth Group Inc — 4.05%
  6. Gsk Plc — 3.00%
  7. Edwards Lifesciences Corp — 2.56%
  8. Intuitive Surgical Inc — 2.52%
  9. CVS Health Corp — 2.52%
  10. Cencora Inc — 2.47%

IDNA top 10

  1. BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 10.39%
  2. Bayer Aktiengesellschaft — 4.81%
  3. Twist Bioscience Corp — 4.79%
  4. Revolution Medicines, Inc. — 4.55%
  5. Regeneron Pharmaceuticals, Inc. — 4.35%
  6. Genmab A/s — 4.23%
  7. Incyte Corporation — 4.23%
  8. Moderna, Inc. — 4.19%
  9. Takeda Pharmaceutical Company Limited — 4.05%
  10. Merck & Co., Inc. — 3.91%

FAQ

What is the difference between VGHCX and IDNA?
VGHCX (Vanguard Health Care Fund) and IDNA (iShares Genomics Immunology and Healthcare ETF) are quite different portfolios: only about 17% of their top holdings (by weight) are shared. VGHCX is cheaper at 0.33% vs 0.47% — a difference of $14 a year per $10,000 invested.
Which is cheaper, VGHCX or IDNA?
VGHCX has the lower expense ratio (0.33%).
Should I own both VGHCX and IDNA?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.